Société Tauriga Sciences, Inc. Other OTC
Actions
TAUG
US87669X2053
Produits pharmaceutiques
Métier
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Seth M. Shaw
CEO | Chief Executive Officer | 45 | 22/08/12 |
Kevin P. Lacey
DFI | Director of Finance/CFO | 55 | 05/07/17 |
Keith A. Aqua
CTO | Chief Tech/Sci/R&D Officer | - | 15/07/20 |
Adina Miles
SAM | Sales & Marketing | - | - |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
James V. Rosati
BRD | Director/Board Member | 74 | 08/03/21 |
Seth M. Shaw
CEO | Chief Executive Officer | 45 | 22/08/12 |
Director/Board Member | 46 | 08/03/21 | |
Director/Board Member | 75 | 05/08/15 |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 1 | 299 908 214 | 299 908 214 ( 100,00 %) | 0 | 100,00 % |
Coordonnées société
Secteur
Varia. 1 janv. | Capi. | |
---|---|---|
+30,38% | 684 Md | |
+26,51% | 568 Md | |
-4,36% | 361 Md | |
+19,30% | 329 Md | |
+3,73% | 284 Md | |
+16,70% | 240 Md | |
+8,78% | 208 Md | |
-7,93% | 200 Md | |
+7,68% | 166 Md |